Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
26,385,773
-
Share change
-
-765,240
-
Total reported value
-
$216,351,759
-
Price per share
-
$8.20
-
Number of holders
-
76
-
Value change
-
-$17,017,220
-
Number of buys
-
33
-
Number of sells
-
35
Institutional Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q4 2017
As of 31 Dec 2017,
AVADEL PHARMACEUTICALS - COM (AVDL) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,385,773 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BRANDES INVESTMENT PARTNERS, LP, Broadfin Capital, LLC, PERCEPTIVE ADVISORS LLC, ARMISTICE CAPITAL, LLC, ACADIAN ASSET MANAGEMENT LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, and BROWN CAPITAL MANAGEMENT LLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.